1. Home
  2. CTMX vs DSY Comparison

CTMX vs DSY Comparison

Compare CTMX & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • DSY
  • Stock Information
  • Founded
  • CTMX 2008
  • DSY 2020
  • Country
  • CTMX United States
  • DSY China
  • Employees
  • CTMX N/A
  • DSY N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • CTMX Health Care
  • DSY
  • Exchange
  • CTMX Nasdaq
  • DSY Nasdaq
  • Market Cap
  • CTMX 60.7M
  • DSY 58.8M
  • IPO Year
  • CTMX 2015
  • DSY N/A
  • Fundamental
  • Price
  • CTMX $1.99
  • DSY $1.47
  • Analyst Decision
  • CTMX Buy
  • DSY
  • Analyst Count
  • CTMX 2
  • DSY 0
  • Target Price
  • CTMX $2.50
  • DSY N/A
  • AVG Volume (30 Days)
  • CTMX 9.5M
  • DSY 57.0K
  • Earning Date
  • CTMX 05-12-2025
  • DSY 02-10-2025
  • Dividend Yield
  • CTMX N/A
  • DSY N/A
  • EPS Growth
  • CTMX 128.27
  • DSY 120.37
  • EPS
  • CTMX 0.49
  • DSY 0.01
  • Revenue
  • CTMX $147,557,000.00
  • DSY $7,323,356.00
  • Revenue This Year
  • CTMX N/A
  • DSY N/A
  • Revenue Next Year
  • CTMX N/A
  • DSY N/A
  • P/E Ratio
  • CTMX $4.90
  • DSY $121.74
  • Revenue Growth
  • CTMX 23.81
  • DSY 16.37
  • 52 Week Low
  • CTMX $0.40
  • DSY $0.75
  • 52 Week High
  • CTMX $2.81
  • DSY $10.75
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 80.26
  • DSY 54.54
  • Support Level
  • CTMX $0.91
  • DSY $1.32
  • Resistance Level
  • CTMX $2.55
  • DSY $1.65
  • Average True Range (ATR)
  • CTMX 0.22
  • DSY 0.15
  • MACD
  • CTMX 0.18
  • DSY 0.01
  • Stochastic Oscillator
  • CTMX 87.53
  • DSY 77.17

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: